{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:15:00Z","timestamp":1793315700172,"version":"4.5.0"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To explore any correlation between serum urate (SU) level or insulin resistance (IR) and metabolic dysfunction associated steatotic liver disease (MASLD) in patients with metabolic syndrome (MS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data from all MASLD patients, diagnosed by liver biopsy, were enrolled and divided into MASLD alone group and MASLD with MS group. They were subdivided into hyperuricemia group and normal SU group to find correlation between SU\/IR and MASLD in patients with MS and independent risk factors for MASLD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Data from 539 MASLD patients were analyzed. Body mass index (BMI) (<jats:italic>p<\/jats:italic>\u2009=\u20090.000), waist circumference (WC) (<jats:italic>p<\/jats:italic>\u2009=\u20090.004), and low-density lipoprotein (LDL) (<jats:italic>p<\/jats:italic>\u2009=\u20090.000) were dramatically higher in MASLD with MS group than those with MASLD alone; MASLD with MS patients had significantly more family history of diabetes (<jats:italic>p<\/jats:italic>\u2009=\u20090.000) and hypertension (<jats:italic>p<\/jats:italic>\u2009=\u20090.000) than patients with MASLD alone. Height (<jats:italic>p<\/jats:italic>\u2009=\u20090.000), weight (<jats:italic>p<\/jats:italic>\u2009=\u20090.000), BMI (<jats:italic>p<\/jats:italic>\u2009=\u20090.000) and WC (<jats:italic>p<\/jats:italic>\u2009=\u20090.001), and LDL (<jats:italic>p<\/jats:italic>\u2009=\u20090.007) were dramatically higher in hyperuricemia patients than those with normal SU. SU was inversely associated with age (<jats:italic>p<\/jats:italic>\u2009=\u20090.000) and high-density lipoprotein (HDL) (<jats:italic>p<\/jats:italic>\u2009=\u20090.003), and positively correlated with weight (<jats:italic>p<\/jats:italic>\u2009=\u20090.000), BMI (<jats:italic>p<\/jats:italic>\u2009=\u20090.000) and WC (<jats:italic>p<\/jats:italic>\u2009=\u20090.000), TG (<jats:italic>p<\/jats:italic>\u2009=\u20090.000), and LDL (<jats:italic>p<\/jats:italic>\u2009=\u20090.000). Logistic Regression analysis showed that age (<jats:italic>p<\/jats:italic>\u2009=\u20090.031), TG (<jats:italic>p<\/jats:italic>\u2009=\u20090.002), LDL (<jats:italic>p<\/jats:italic>\u2009=\u20090.010), HbA1c (<jats:italic>p<\/jats:italic>\u2009=\u20090.026), and family history of hypertension (<jats:italic>p<\/jats:italic>\u2009=\u20090.000) may be independent risk factors for MASLD in patient with MS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Insulin resistance (IR) in MASLD patients with MS, but not higher SU levels, has closer correlation with the occurrence of MASLD in patients with family history of hypertension and diabetes having higher BMI, LDL, HbA1c.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2024.1384927","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T04:41:02Z","timestamp":1731645662000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Insulin resistance has closer correlation with the occurrence of metabolic dysfunction associated steatotic liver disease diagnosed by liver biopsy"],"prefix":"10.3389","volume":"11","author":[{"given":"Weihua","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjiao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxiao","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leiping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,15]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1469492","DOI":"10.3389\/fcvm.2024.1469492","article-title":"Drivers of cardiovascular disease in metabolic dysfunction-associated steatotic liver disease: the threats of oxidative stress","volume":"11","author":"Minetti","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/j.1440-1746.2010.06509.x","article-title":"Non-alcoholic fatty liver disease\u2019s prevalence and impact on alanine aminotransferase associated with metabolic syndrome in the Chinese","volume":"26","author":"Hou","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-metaanalytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.cld.2009.07.005","article-title":"Epidemiology and natural history of nonalcoholic steatohepatitis","volume":"13","author":"Argo","year":"2009","journal-title":"Clin Liver Dis"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"9338","DOI":"10.3748\/wjg.v20.i28.9338","article-title":"The role of dietary and lifestyle changes in non-alcoholic fatty liver disease","volume":"20","author":"Nseir","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/978-3-319-48382-5_19","article-title":"Non-alcoholic fatty liver disease","volume":"960","author":"Engin","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1053\/j.gastro.2018.08.024","article-title":"Risk of hepatocellular carcinoma in patients with non-alcoholic fatty liver disease","volume":"155","author":"Kanwal","year":"2018","journal-title":"Gastroenterology"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1111\/jgh.14608","article-title":"Clinical characteristics of hepatocellular carcinoma in patients with non-alcoholic fatty liver disease","volume":"34","author":"Kodama","year":"2019","journal-title":"J Gastrointest Liver Dis"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1053\/gast.2001.25540","article-title":"Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese","volume":"121","author":"Dixon","year":"2001","journal-title":"Gastroenterology"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1111\/j.1572-0241.2003.07486.x","article-title":"The prevalence and etiology of elevated aminotransferase levels in the United States","volume":"98","author":"Clark","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.cld.2007.02.011","article-title":"Pathogenesis of non-alcoholicsteatohepatitis: human data","volume":"11","author":"Edmison","year":"2007","journal-title":"Clin Liver Dis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cmet.2007.05.005","article-title":"Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver","volume":"6","author":"Monetti","year":"2007","journal-title":"Cell Metab"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1042\/CS20080306","article-title":"The DGAT2 gene is a candidate for the dissociation between fatty liver and insulin resistance in humans","volume":"116","author":"Kantartzis","year":"2009","journal-title":"Clin Sci (Lond)"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.bbalip.2011.06.021","article-title":"Phosphatidylcholine protects against steatosis in mice but not non-alcoholic steatohepatitis","volume":"1811","author":"Niebergall","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","article-title":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome","volume":"2","author":"Yki-J\u00e4rvinen","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1001\/archinte.164.19.2169","article-title":"Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults","volume":"164","author":"Kim","year":"2004","journal-title":"Arch Intern Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/ajg.2011.400","article-title":"Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults","volume":"107","author":"Sinn","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"101409","DOI":"10.1016\/j.molmet.2021.101409","article-title":"The metabolic syndrome, thiazolidinediones, and implications for intersection of chronic and inflammatory disease","volume":"55","author":"Colca","year":"2022","journal-title":"Mol Metab"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/hep4.1696","article-title":"Ipragliflozin improves the hepatic outcomes of patients with diabetes with NAFLD","volume":"6","author":"Takahashi","year":"2022","journal-title":"Hepatol Commun"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"22063","DOI":"10.1038\/s41598-021-01663-y","article-title":"A meta-analysis of the effects of glucagon-like-peptide 1 receptor agonist (GLP1-RA) in nonalcoholic fatty liver disease (NAFLD) with type 2 diabetes (T2D)","volume":"11","author":"Ghosal","year":"2021","journal-title":"Sci Rep"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"8936865","DOI":"10.1155\/2021\/8936865","article-title":"GLP-1 receptor agonist effects on lipid and liver profiles in patients with nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"2021","author":"Rezaei","year":"2021","journal-title":"Can J Gastroenterol Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Non alcoholic fatty liver disease, steatohepatitis, and metabolic syndrome","volume":"37","author":"Marchesini","year":"2003","journal-title":"Hepatology"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.ejim.2014.05.012","article-title":"Non alcoholic fatty liver disease, metabolic syndrome, and protein 3 gene variants containing patatin like phospholipase domains","volume":"25","author":"Del Ben","year":"2014","journal-title":"Eur J Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3390\/ijms17030367","article-title":"Bidirectional relationships and disconnects between NAFLD and features of the metabolic syndrome","volume":"17","author":"Wainwright","year":"2016","journal-title":"Int J Mol Sci"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11906-018-0812-z","article-title":"The global epidemic of the metabolic syndrome","volume":"20","author":"Saklayen","year":"2018","journal-title":"Curr Hypertens Rep"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/BF00163854","article-title":"Two independent mutational events in the loss of urate oxidase during hominoid evolution","volume":"34","author":"Wu","year":"1992","journal-title":"J Mol Evol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1172\/JCI42344","article-title":"Uric acid transport and disease","volume":"120","author":"So","year":"2010","journal-title":"J Clin Invest"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3389\/fphys.2019.01323","article-title":"Interaction between ITM2B and GLUT9 links urate transport to neurodegenerative disorders","volume":"10","author":"Mandal","year":"2019","journal-title":"Front Physiol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.2174\/138161205774913273","article-title":"Dietary factors and hyperuricaemia","volume":"11","author":"Schlesinger","year":"2005","journal-title":"Curr Pharm Des"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev-physiol-021113-170343","article-title":"The molecular physiology of uric acid homeostasis","volume":"77","author":"Mandal","year":"2015","journal-title":"Annu Rev Physiol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1053\/j.ackd.2012.07.009","article-title":"Renal transport of uric acid: evolving concepts and uncertainties","volume":"19","author":"Bobulescu","year":"2012","journal-title":"Adv Chronic Kidney Dis"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/BOR.0b013e3282f33f87","article-title":"Control of renal uric acid excretion and gout","volume":"20","author":"Taniguchi","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"762820","DOI":"10.1155\/2015\/762820","article-title":"Prevalence of hyperuricemia and gout in mainland China from 2000 to 2014: a systematic review and meta-analysis","volume":"2015","author":"Liu","year":"2015","journal-title":"Biomed Res Int"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e00291","DOI":"10.1002\/prp2.291","article-title":"Uricosuric targets of tranilast","volume":"5","author":"Mandal","year":"2017","journal-title":"Pharmacol Res Perspect"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ejim.2022.04.022","article-title":"Uric acid in metabolic syndrome: does uric acid have a definitive role?","volume":"103","author":"Copur","year":"2022","journal-title":"Eur J Intern Med"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"713710","DOI":"10.3389\/fphys.2021.713710","article-title":"Genetic and physiological effects of insulin on human urate homeostasis","volume":"12","author":"Mandal","year":"2021","journal-title":"Front Physiol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00240-016-0956-8","article-title":"Kidney stones diseases and glycaemic statuses: focus on the latest clinical evidences","volume":"45","author":"Spatola","year":"2017","journal-title":"Urolithiasis"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"172","DOI":"10.5455\/medarh.2020.74.172-176","article-title":"Comparison of the effects of allopurinol and febuxostat on the values of triglycerides in hyperuricemic patients","volume":"74","author":"Ziga-Smajic","year":"2020","journal-title":"Med Arch"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"G42","DOI":"10.1152\/ajpgi.00443.2014","article-title":"The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model","volume":"309","author":"Nakatsu","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1016\/j.cgh.2019.12.026","article-title":"Nonalcoholic fatty liver disease and fibrosis associated with increased risk of cardiovascular events in a prospective study","volume":"18","author":"Baratta","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1136\/gutjnl-2020-323082","article-title":"Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis","volume":"71","author":"Mantovani","year":"2022","journal-title":"Gut"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASD&EASO clinical practice guidelines for the management of nonalcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1056\/NEJMoa2401943","article-title":"Tirzepatide for metabolic dysfunction-associated steatohepatitis with liver fibrosis","volume":"391","author":"Loomba","year":"2024","journal-title":"N Engl J Med"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1016\/j.cmet.2024.07.013","article-title":"Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH","volume":"36","author":"Tao","year":"2024","journal-title":"Cell Metab"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"S2468-1253(24)00246-00242","DOI":"10.1016\/S2468-1253(24)00246-2","article-title":"Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2b trial. Lancet","volume":"10","author":"Loomba","year":"2024","journal-title":"Gastroenterol Hepatol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/hep.22292","article-title":"Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease","volume":"47","author":"Dunn","year":"2008","journal-title":"Hepatology"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s12325-017-0556-1","article-title":"NAFLD as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk","volume":"34","author":"Ballestri","year":"2017","journal-title":"Adv Ther"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3390\/children10020233","article-title":"Is metabolic syndrome useful for identifying youths with obesity at risk for NAFLD?","volume":"10","author":"Di Bonito","year":"2023","journal-title":"Children (Basel)"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.3390\/ijms21082890","article-title":"Microbial medicine: prebiotic and probiotic functional foods to target obesity and metabolic syndrome","volume":"21","author":"Green","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/vox.12029","article-title":"Haemoglobin glycation (Hb1Ac) increases during red blood cell storage: a MALDI-TOF mass-spectrometry-based investigation","volume":"105","author":"D'Alessandro","year":"2013","journal-title":"Vox Sang"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12944-018-0678-8","article-title":"Erratum in: A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease","volume":"17","author":"Chen","year":"2018","journal-title":"Lipids Health Dis"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1681\/ASN.2007040416","article-title":"Thiazide diuretics exacerbate fructose-induced metabolic syndrome","volume":"18","author":"Reungjui","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"742411","DOI":"10.3389\/fendo.2021.742411","article-title":"Uric acid mediated the association between BMI and postmenopausal breast Cancer incidence: a bidirectional Mendelian randomization analysis and prospective cohort study","volume":"12","author":"Feng","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1186\/s12889-022-14357-5","article-title":"Association between nutrient patterns and hyperuricemia: mediation analysis involving obesity indicators in the NHANES","volume":"22","author":"Wang","year":"2022","journal-title":"BMC Public Health"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1384927\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T04:41:06Z","timestamp":1731645666000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1384927\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,15]]},"references-count":55,"alternative-id":["10.3389\/fmed.2024.1384927"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1384927","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,15]]},"article-number":"1384927"}}